Prioritizing Growth Investment While Increasing the Dividend Payout Ratio
First written in FY2019. 13 of 19 entries say "Restated". Latest entry: 2026-08-14.
- FY2026-H1RestatedAnnual report
「19 December 2025 Annual General Meeting of Shareholders Common shares 390 4.00」
The dividend for the fiscal year ended September 2025 was ¥390 million in total, or ¥4 per share, unchanged from the previous fiscal year. - FY2024AdvancedAnnual report
「Based on these policies, the year-end dividend for the fiscal year is ¥4 per share.」
While maintaining the policy centered on stable dividends and securing retained earnings, the year-end dividend increased from ¥3 per share in the previous fiscal year to ¥4. - FY2024-Q1RestatedAnnual report
「22 December 2023 Annual General Meeting of Shareholders Common shares Total dividends: ¥294 million Dividend per share: ¥3.00」
The filing states that the Company paid a year-end dividend of ¥294 million, or ¥3 per share, for the fiscal year ended September 2023. No change in the shareholder return policy itself was indicated. - FY2023-Q3RestatedAnnual report
「23 December 2022 Annual General Meeting of Shareholders Common shares Total dividends: ¥293 million Dividend per share: ¥6.00」
The filing reconfirms that the Company paid a dividend of ¥293 million, or ¥6 per share, for the fiscal year ended September 2022. - FY2023-Q2RestatedAnnual report
「23 December 2022 Annual General Meeting of Shareholders Common shares Total dividends: ¥293 million Dividend per share: ¥6.00」
The filing reconfirms that the Company paid a dividend of ¥293 million, or ¥6 per share, for the fiscal year ended September 2022. - FY2022ReframedAnnual report
「The Company regards the distribution of profits to shareholders as an important management issue. Its basic policy is to pay an annual year-end dividend, with stable shareholder returns as the foundation, while securing retained earnings for business expansion into the 医心館 business and related areas and for strengthening its management foundation, taking into comprehensive consideration market conditions, regulatory trends and financial soundness. Over the medium to long term, the Company intends to focus on total shareholder return and provide stable returns regardless of changes in its growth stage.」
The policy wording has expanded from one premised on securing retained earnings for growth investment to one emphasizing stable dividends and medium- to long-term total shareholder return. The year-end dividend for the fiscal year was ¥6 per share. - FY2022-Q2RestatedAnnual report
「24 December 2021 Annual General Meeting of Shareholders Common shares Total dividends: ¥218 million Dividend per share: ¥9」
The filing states that the Company paid a year-end dividend of ¥218 million, or ¥9 per share, for the fiscal year ended September 2021. - FY2022-Q1RestatedAnnual report
「24 December 2021 Annual General Meeting of Shareholders Common shares Total dividends: ¥218 million Dividend per share: ¥9」
The filing states that the Company paid a year-end dividend of ¥218 million, or ¥9 per share, for the fiscal year ended September 2021. - FY2021AdvancedAnnual report
「Based on these policies, the year-end dividend for the fiscal year is ¥9 per share.」
The wording of the dividend policy continues to emphasize securing retained earnings, as in the previous year, while the dividend per share increased from ¥6 to ¥9 and the payout ratio was 43.95%. - FY2021-Q3RestatedAnnual report
「25 December 2020 Annual General Meeting of Shareholders Common shares Total dividends: ¥135 million Dividend per share: ¥6」
The filing restates that the Company paid a dividend of ¥135 million, or ¥6 per share, for the fiscal year ended September 2020, and indicates no change in the policy of paying dividends while prioritizing growth investment. - FY2021-Q2RestatedAnnual report
「25 December 2020 Annual General Meeting of Shareholders Common shares Total dividends: ¥135 million Dividend per share: ¥6」
The Company paid a dividend of ¥135 million, or ¥6 per share, for the fiscal year ended September 2020. No change was indicated in the policy of paying dividends while prioritizing growth investment. - FY2021-Q1RestatedAnnual report
「25 December 2020 Annual General Meeting of Shareholders Common shares Total dividends: ¥135 million Dividend per share: ¥6」
The Company paid a dividend of ¥135 million, or ¥6 per share, for the fiscal year ended September 2020. The dividend per share was unchanged from the previous year, and no change was indicated in the policy of paying dividends while prioritizing growth investment. - FY2020SoftenedAnnual report
「The Company regards the distribution of profits to shareholders as an important management issue. Its basic policy is to pay an annual year-end dividend while securing retained earnings for business expansion into the 医心館 business and related areas and for strengthening its management foundation, taking into comprehensive consideration market conditions, regulatory trends and financial soundness.」
The explicit reference to a future increase in the payout ratio included in the previous year is absent, and the wording has changed to emphasize securing retained earnings for business expansion and strengthening the management foundation. The dividend for the fiscal year was ¥6 per share. - FY2020-Q3RestatedAnnual report
「25 December 2019 Annual General Meeting of Shareholders Common shares Total dividends ¥60.000 million Dividend per share ¥6」
The filing restates the payment of a dividend of ¥60 million, or ¥6 per share, for the fiscal year ended September 2019, and indicates no change in the policy of prioritizing growth investment while raising the payout ratio in the future. - FY2020-Q2RestatedAnnual report
「25 December 2019 Annual General Meeting of Shareholders Common shares Total dividends ¥60.000 million Dividend per share ¥6」
Reiterates payment of ¥60.000 million in dividends, or ¥6 per share, for the fiscal year ended September 2019. No change is indicated in the policy of prioritizing growth investment while increasing the dividend payout ratio in the future. - FY2020-Q1RestatedAnnual report
「25 December 2019 Annual General Meeting of Shareholders Common shares Total dividends ¥60.000 million Dividend per share ¥6」
Discloses payment of ¥60.000 million in dividends, or ¥6 per share, for the fiscal year ended September 2019. No change is indicated in the policy of increasing the dividend payout ratio. - FY2019First statedAnnual report
「For the fiscal year ended September 2019, the dividend payout ratio was 10%. Going forward, the Company plans to increase the payout ratio over the medium to long term, taking sufficient account of the balance between business growth and returns to shareholders, business performance trends from a medium- to long-term perspective, and dividend conditions at listed companies.」
While allocating retained earnings actively to the Ishinkan business, the Company pays dividends after taking operating performance and financial position into account, and has stated its intention to raise the dividend payout ratio in the future.